On February 6, 2025, URGENT: VOLUNTARY MEDICAL DEVICE RECALL letters were sent to customers. Actions to be Taken by Customers:
1. If you do have units of the affected product listed in Table 1, remove them immediately from service and quarantine
them.
2. If you do have affected product, check the box on the enclosed Acknowledgement Form I do have affected product.
Record the lot number(s) and total quantity of the affected product that you have.
3. Forward this notice to those who utilize the product so they are aware of this recall and can identify and quarantine any affected
product that may remain in clinical areas.
4. If you do not have affected product, check the box, I do not have affected product.
5. Complete the rest of the Acknowledgement Form and return to
[email protected] or FAX to 1-609-750- 4220.
6. Keep a copy of the form for your records.
7. When your form is received, and it is noted that you have affected product, Customer Service will contact you and provide a
Return Material Authorization (RMA) number and directions to return the affected product. You can request a credit for the
quantities returned. Please note credit is applicable only for unexpired product.
Receipt of this form ensures that Integra has achieved a level of effectiveness in communicating this information. We recommend
you also maintain a copy of this notification and the signed copy of the acknowledgement form for your records. Regulatory agencies
such as the FDA perform audits of field actions of this nature to verify that our customers have been notified and understand the nature
of the field action.
Should you have any questions regarding these instructions, please contact Customer Service: Monday to
Friday 8:00 AM 8:00 PM EST
USA: 1-800-654-2873: email:
[email protected]
In addition, adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch
Adverse Event Reporting program either online, by regular mai